A case report of uveitis secondary to dupilumab treatment for atopic dermatitis

JAAD Case Rep. 2020 Nov 19:7:98-99. doi: 10.1016/j.jdcr.2020.11.012. eCollection 2021 Jan.

Authors

Marissa Ayasse¹, Benjamin Lockshin², Brian K Do³, Rachel Kaiser⁴, Jonathan I Silverberg¹

Affiliations

¹ Department of Dermatology, The George Washington University School of Medicine and Health Sciences, Washington, District of Columbia.
² DermAssociates, Silver Spring, Maryland.
³ The Retina Group of Washington, Chevy Chase, Maryland.
⁴ Arthritis and Rheumatism Associates, Chevy Chase, Maryland.

No abstract available

Keywords: AD, atopic dermatitis; IL, interleukin; adverse effect; atopic dermatitis; dupilumab; eczema; treatment; uveitis.

Publication types

Case Reports